Taste in Medical Technology

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders

... body odor (probably caused by its metabolite phenylacetate) and bad taste or taste aversion. Patients with urea cycle disorders should not take valproic ...

Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders

... body odor (probably caused by its metabolite phenylacetate) and bad taste or taste aversion. Patients with urea cycle disorders should not take valproic ...

Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders

... body odor (probably caused by its metabolite phenylacetate) and bad taste or taste aversion. Patients with urea cycle disorders should not take valproic ...

MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study

... Rx's intellectual property includes thin film producing polymers, drug taste masking, processes that ensure product and content uniformity at scale, ... a novel process and proprietary encapsulation compositions to mask the taste of the drug contained within the film. The Company's thin film ...

Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia

... 1.4%, Biaxin 1.0%), abdominal pain (cethromycin 1.4%, Biaxin 1.4%) and taste disturbance (cethromycin 7.6%, Biaxin 2.1%). No drug-related serious ... (4/288) (4/291) (4/260) (8/257) (8/548) (12/548) taste Disturbance 7.6% 2.1% 11.2% 6.2% 9.3% 4.0% ...

Hyperion Therapeutics Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of GT4P in Patients With Urea Cycle Disorders

... body odor (probably caused by its metabolite phenylacetate) and bad taste or taste aversion. Patients with urea cycle disorders should not take valproic ...

July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals

... or call toll-free for subscription information, 1-800-876-8633, extension 9751. Foods may look, smell and even taste fine -- and still harbor bacteria that can cause food poisoning. The July issue of Mayo Clinic Women's HealthSource provides an overview of food ...

July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook, Bell's Palsy and Heart Valve Repair

... eye with tears dripping from the corner Pain around the ear or jaw, ringing in the ears, sensitivity to noise Headache Loss of taste or a decrease in saliva production Bell's palsy can affect anyone, at any age. The risk rises until about age 40 and then begins to ...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

... DANONE RESEARCH. Over the past 90 years, DANONE has amassed a collection of approximately 3,500 lactic bacteria strains or "cultures." In addition to taste and texture, some of these cultures provide probiotic health properties. Such is the case of Bifidobacterium animalis DN 173 010, used to produce ...

Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial

... generally safe and well tolerated. There were no serious adverse events. The only common side effect reported (> 10% in any treatment group) was taste (dysgeusia). This side effect was rated as mild in all patients and occurred in both drug and placebo dose groups. ...

K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers' Grains

... mid-1980s, K-State meat science researchers were asked to study the possibility of reducing the percentage of fat in ground beef without compromising taste and texture. As the K-State researchers studied ground beef with differing proportions of fat, they observed how the meats cooked and noted that ...

FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months

... lead to blindness if not treated right away. More common side effects are tingling in arms and legs, loss of appetite, tiredness, nausea, diarrhea, taste change and weight loss. Headquartered in Titusville, NJ, Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., focuses ...

Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product

... Its founding partner, Richard C. Fuisz, M.D., is a noted pharmaceutical inventor, including in the thin film drug delivery, quick dissolve tablet, taste masking and controlled release fields ( http://www.en.wikipedia.org/wiki/Richard_Fuisz ). Fuisz Tobacco's managing partner, Joseph Fuisz, is a ...

Low Acid Coffee Backed By Scientific Research

... "88% of respondents stated Puroast(R) provided relief of their gut symptoms caused by coffee, and 95% said they would purchase the product again, taste being a key factor. These are extraordinarily high numbers for any product with its target consumer." Puroast(R) and Dr. Euler are now expanding ...

Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm

... of dosing in the short-duration AF group. The most common adverse events (AEs) reported within the first 24 hours in patients given KYNAPID were taste disturbance (29.9%), sneezing (16.3%), skin sensation (10.9%), nausea (9%), and hypotension (6.3%). These events were generally transient. Four ...

American Heart Association Journal Report: Reducing Kids' Salt Intake May Lower Soft Drink Consumption, Reducing Obesity, High Blood Pressure and Later Health Risks

... impact food taste, she said. "Small reductions in the salt content of 10 percent to 20 percent cannot be detected by the human salt taste receptors and do not cause any technological or safety problems," Dr. He said. In a related Hypertension editorial, Myron H. Weinberger, M.D., ...

FASgen Announces a New Discovery in Obesity Research

... and produced in vivo results in mice of decreased feeding for three days and persistent weight loss of six days, with no evidence of conditioned taste aversion. See, "Pharmacological Stimulation of Brain Carnitine-Transerase-1 Decreases Food Intake and Body Weight," Ronnett, et al, Am J Physiol ...

Orapred ODT Tastes Good

... The results also showed that 83% (n=809) of the respondents liked the taste of Orapred ODT, and 97% (n=942) said Orapred ODT was easy to take. In ... pleased to see that, based on these results; patients appreciate both the taste and convenience that Orapred ODT has to offer." Orapred ODT utilizes a ...

Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis

... initiation, timing and results of a 6-month nasal toxicology study; the importance and potential differentiating quality of the product candidate's taste profile; and the timing or outcome of the Company's meetings with the FDA regarding the epinastine nasal spray clinical program. Such forward-looking ...

Data Suggest that Pegasys May be an Option in Hepatitis C Patients Unable to Tolerate Peg-Intron

... COPEGUS are: -- Flu-like symptoms (including fever, chills, muscle aches, joint pain, headaches) -- Tiredness -- Upset stomach (like nausea, taste changes, diarrhea) -- Blood sugar problems (may lead to diabetes) -- Skin problems (like rash, dry or itchy skin, redness and swelling at ...

Pegasys Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered ''Cured''

... COPEGUS are: -- Flu-like symptoms (including fever, chills, muscle aches, joint pain, headaches) -- Tiredness -- Upset stomach (like nausea, taste changes, diarrhea) -- Blood sugar problems (may lead to diabetes) -- Skin problems (like rash, dry or itchy skin, redness and swelling at ...

Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial

... 6.5%), nausea (cethromycin 2.7%, Biaxin(R) 3.8%), vomiting (cethromycin 2.7%, Biaxin(R) 1.5%), abdominal pain (cethromycin 1.5%, Biaxin(R) 3.1%) and taste disturbance (cethromycin 11.1%, Biaxin(R) 6.2%). No drug-related serious adverse events were observed in any study subject. Liver function tests and ...

Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent

... sensitivity to mouse or hamster proteins. The most common related adverse reactions observed during the ADVATE clinical studies include: strange taste in mouth, headache, dizziness and flushing. The formation of inhibitors has been observed with all factor VIII concentrates, including ADVATE. ...